Milestone Pharmaceuticals (NASDAQ-MIST) Stock Price Today • Wrapstocks

$1.75

24H

0.27%

Market Cap

92.8 M

Volume

1.9 K

Supply

53.1 M

Price Chart

About Milestone Pharmaceuticals - MIST

Milestone Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative cardiovascular medicines, particularly those addressing cardiac arrhythmias. Their lead product candidate, etripamil, is a novel short-acting calcium channel blocker designed for the treatment of paroxysmal supraventricular tachycardia (PSVT), a rapid heart rate condition.

Milestone Pharmaceuticals Inc.'s core mission is dedicated to developing and providing innovative cardiovascular medicines to improve the lives of patients with heart conditions. Their core values are centered around scientific excellence, innovation, patient focus, and integrity in their pursuit of creating therapies that address unmet medical needs.

Milestone Pharmaceuticals Inc. was founded by Philippe Douville in 2005.

As of the last update available, Joseph Oliveto serves as the President and CEO of Milestone Pharmaceuticals Inc. Please verify with the most current sources to confirm if there have been any changes in leadership.

Milestone Pharmaceuticals Inc. is headquartered in Montreal, Quebec, Canada, which is its base country.

Milestone Pharmaceuticals Inc. is traded on the NASDAQ stock exchange under the ticker symbol MIST.

Milestone Pharmaceuticals (MIST) Price Live Data

The live price of Milestone Pharmaceuticals (MIST) is $1.75, with a trading volume of 1,855 in the last 24 hours. Wrapstocks updates the MIST price in real-time. Milestone Pharmaceuticals is down -0.27% in the last 24 hours. The company has a live market cap of $92,757,032.00 and a supply of 53,149,801 MIST stocks.

Milestone Pharmaceuticals (MIST) is traded on NASDAQ Stock Exchange, and currently, the market is open; trading will be paused in 5 hours and 30 minutes.

NASDAQ

NASDAQ Stock Exchange